Research and reconstructionsThursday, December 5, 2019
In an interview with Dr Soosan Jacob, Prof Madeleine Zetterberg describes the Swedish Opthalmological Society’s annual meeting.
Wine in paradiseThursday, December 5, 2019
Illustration by Eoin Coveney What is the #1 red grape variety in Italy, as measured by total wine production?” I asked, as the nine other members took their seats, pen and paper in one hand and a Chianti in the other. The first Friday of the month had finally arrived, and for us, that means: […]
Driving RevenuesThursday, December 5, 2019
Carones and Malley challenged surgeons to assess their effectiveness in various aspects of their clinics.
Gender inequality in ophthalmologyTuesday, October 1, 2019
Improving women’s experiences in the workplace improves life for everyone
Consultations project wins Innovation PrizeMonday, September 16, 2019
Julien Buratto won the inaugural Innovation Prize at the ESCRS Practice Management and Development Programme
Delving deeper into refractive surgerySunday, September 1, 2019
Refractive surgery is, for the most part, spectacularly successful and proceeds complication-free.
Software updateSunday, September 1, 2019
OD-OS has released a new software update for its Navilas 577s.
A re-evaluation of a constant threatSunday, September 1, 2019
The risk of endophthalmitis was, until relatively recently, on every cataract surgeon’s mind during and after every single procedure.
Take off your maskSunday, September 1, 2019
Leigh Spielberg MD reflects on the momentary blindness he experienced during a scuba diving lesson
Aerie in EuropeSunday, September 1, 2019
Aerie’s recently completed state-of-the-art sterile fill facility in Athlone, Ireland With US Food and Drug Administration approval of its first product in December 2017, newcomer Aerie Pharmaceuticals made history. The company’s proprietary Rho kinase (ROCK) inhibitor eye drop, Rhopressa (netarsudil ophthalmic solution) 0.02%, represented the first new drug class approved in the US for reducing […]